Category: Middle East and North Africa

September 29, 2015 Off

Eli Lilly, Incyte: positive top-line results of RA-BEGIN

By Dino Mustafić

Eli Lilly and Company and Incyte Corporation have announced positive top-line results of RA-BEGIN, the third Phase 3 study evaluating the safety and efficacy of baricitinib, an investigational medicine for patients with moderately-to-severely active rheumatoid arthritis (RA).

September 14, 2015 Off

Hikma buys 98.09% of EUP

By Dino Mustafić

Hikma Pharmaceuticals PLC, a multinational pharmaceutical group, has agreed to acquire 98.09% of the share capital of EIMC United Pharmaceuticals (EUP)…